RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @Adam_Russak: We demonstrate anticoagulation may be associated with improved outcomes in hospitalized patients with COVID-19. RCT neede…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
AN RCT is urgently required! Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID19 https://t.co/yVHDUaHT3s
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even if it is published in a big journal https://t.co/eXCkLhlb8i Read Immortal Time Bias. Here is a COVID pt treated with “preventive
RT @GBarnesMD: Ido - I agree, the paper does not answer the question "how best to prevent #thrombosis in #COVID19?" However, it does provid…
RT @Cardio_delaGuia: Anticoagulación (AC) y Supervivencia Hospitalaria #COVID19 @JACCJournals ▪️ El 28% recibieron AC sistémica ▪️ Los que…
Ido - I agree, the paper does not answer the question "how best to prevent #thrombosis in #COVID19?" However, it does provide further justification for a well conducted RCT. I think the authors did a good job outlining the many limitations of their analysi
RCT of Anticoagulation/ACEi, may well hold some answers to the catastrophic consequences of #COVID19, even if they are not addressing the causes but the consequences of the syndrome
RT @Icomem_Oficial: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID-19 #JAC…
RT @EmilyBlyth5: Published in @JACCJournals #Anticoagulation in 2773 #Covid_19 patients admitted to Mt Sinai. Improved mortality in those t…
ICYMI: Anticoagulants in #COVID19, an observational study. @UTSWIMchief @UTSWInternalMed @UTSWInfDis @UTSWCardfellow @BradCutrellMD @DrJulieTMD @RicardoLaHozMD @TperlTrish @michael_shiloh @InternFrench @DinoKazi @WallyOmarMD https://t.co/D5xgoFTInQ
RT @DrDerekConnolly: An observational study of antiocoagulants in #COVID19 🇺🇸 In patients who required ventilation (N=395) in-hospital mo…
RT @Dr_Cit: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/…
RT @DrDerekConnolly: An observational study of antiocoagulants in #COVID19 🇺🇸 In patients who required ventilation (N=395) in-hospital mo…
Longer duration of anticoagulation associated with HR 0.86 of mortality among 395 ventilated patients in a retrospective observational study https://t.co/DZpa1SSyF7 https://t.co/7m5hB8EREt
An observational study of antiocoagulants in #COVID19 🇺🇸 In patients who required ventilation (N=395) in-hospital mortality was 29.1% for those treated with anticoagulants ✅ compared to 62.7%in patients who were not🚫 https://t.co/8XiPe1k6d0 @DrAsifQas
RT @CardioIAN: @CardioIAN @MihaiTrofenciuc
RT @FZores: une étude observationnelle indiquerait que les anticoagulants en cas de COVID19 sont associés à une baisse de la mortalité (not…
RT @Adam_Russak: We demonstrate anticoagulation may be associated with improved outcomes in hospitalized patients with COVID-19. RCT neede…
@CardioIAN @MihaiTrofenciuc
RT @Dr_Cit: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/…
RT @Dr_Cit: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/…
RT @mirvatalasnag: Important🧵 #OAC #COVID19 🔸Routine use of OAC @ study center, so control arm were those w contraindication (observational…
RT @Dr_Cit: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/…
RT @FZores: une étude observationnelle indiquerait que les anticoagulants en cas de COVID19 sont associés à une baisse de la mortalité (not…
RT @eduolpe: Un estudio observacional con 2.773 pacientes, liderado por el Dr. Fuster @CNIC_CARDIO @MountSinaiNYC, muestra que el tratamien…
RT @FZores: une étude observationnelle indiquerait que les anticoagulants en cas de COVID19 sont associés à une baisse de la mortalité (not…
RT @ProfMakris: Short report (too short) of an observational study suggests that fully anticoagulated patients do better in terms of surviv…
RT @Angiologist: Does this paper answer the question of FULL DOSE anticoagulation in #COVID19? I don't think so @JACCJournals... e.g. limi…
RT @mirvatalasnag: Important🧵 #OAC #COVID19 🔸Routine use of OAC @ study center, so control arm were those w contraindication (observational…
RT @Angiologist: Does this paper answer the question of FULL DOSE anticoagulation in #COVID19? I don't think so @JACCJournals... e.g. limi…
Mt. Sinain sairaalasta ensimmäinen vertailuotos antikoagulanttihoidon tehosta COVID-19-potilailla näyttäisi alustavasti tukevan ajatusta, että veren hyytyminen on yksi riskitekijä taudin komplikaatioissa ja hengityskoneen käytön tarpeessa. #COVID-19.
RT @hotdoc7788: Definitivamente las mas ominosas complicaciones de COVID-19 son inmunotromboticas. https://t.co/MwpBPT7eEV
RT @StephenLap: New paper in @JACCJournals suggesting a benefit of therapeutic anticoagulation in #COVID19. This is a retrospective study &…
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @StephenLap: New paper in @JACCJournals suggesting a benefit of therapeutic anticoagulation in #COVID19. This is a retrospective study &…
Promising...
RT @MattMollpulmccm: Very nice comments. Important study, not definitive, not an rct. Thanks @aakonc @MiddeldorpS @connors_md
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
Pretty important findings. Anticoagulation is a very important management consideration early in the hospital course of #COVID19 patients.
RT @MiddeldorpS: Full dose AC seems to be protective. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospita…
Definitivamente las mas ominosas complicaciones de COVID-19 son inmunotromboticas. https://t.co/MwpBPT7eEV
RT @Cardio_delaGuia: Anticoagulación (AC) y Supervivencia Hospitalaria #COVID19 @JACCJournals ▪️ El 28% recibieron AC sistémica ▪️ Los que…
“Findings suggest that systemic AC may be associated with improved outcomes among patients hospitalized with COVID-19. The potential benefits of systemic AC, however, need to be weighed against the risk of bleeding and should be individualized.”
RT @schneiderleonid: Folks, it #heparin now. Brace yourselves for a new wild ride.
RT @Bmayzing: Seems promising and consistent with the sig if any burden of PE I’ve seen in covid patients. Might start empirically AC soon.…
Seems promising and consistent with the sig if any burden of PE I’ve seen in covid patients. Might start empirically AC soon. Would like to hear others thoughts. #covid19 #covid4MDs https://t.co/uFBF86kBil
RT @jaybvarkey: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 by @dranu…
RT @Cardio_delaGuia: Anticoagulación (AC) y Supervivencia Hospitalaria #COVID19 @JACCJournals ▪️ El 28% recibieron AC sistémica ▪️ Los que…
New paper in @JACCJournals suggesting a benefit of therapeutic anticoagulation in #COVID19. This is a retrospective study & the authors address limitations (below). Many other methodological concerns. Interesting, but not enough to change practice yet!
RT @jsenior64: Encontraron la solución a la infección! Curvas de supervivencia espectaculares! Un momento, es una cohorte no un ensayo clín…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/Cka6edK4UT #covid19 #coronavirus #sars-cov2 #covid-19 #breaking #medicine #health #drugs #help #science
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @VivienHLee: Among 2773 #COVID19 patients at Mt Sinai #NYC, 28% received systemic Anticoagulation. Anticoagulation was associated with r…
RT @TKFM_Sakamoto: COVID19入院中の抗凝固療法の有無と生存率の関係。 人工呼吸器管理が必要な症例では抗凝固療法施行を行っていた方が生存率が良かったとのこと。 COVID19の病態の一つとしての血栓症の関与と治療法としての選択肢は外堀が埋められてきた印象。
RT @j_alvarezgarcia: 📣El uso de anticoagulación pdría relacionarse con mejor pronóstico en pacientes hospitalizados por #COVID19 👉Importan…
RT @jsenior64: Encontraron la solución a la infección! Curvas de supervivencia espectaculares! Un momento, es una cohorte no un ensayo clín…
RT @jsenior64: Otra cohorte que sugiere que anticoagular los pacientes es benéfico. Como? Por qué? Comparado con que? https://t.co/OGKGtZ3I…
Encontraron la solución a la infección! Curvas de supervivencia espectaculares! Un momento, es una cohorte no un ensayo clínico. Otra cohorte! En esta época usted puede darle todo lo que se le ocurra a los pacientes sin evidencia y después lo publica. http
RT @jsenior64: Otra cohorte que sugiere que anticoagular los pacientes es benéfico. Como? Por qué? Comparado con que? https://t.co/OGKGtZ3I…
Otra cohorte que sugiere que anticoagular los pacientes es benéfico. Como? Por qué? Comparado con que? https://t.co/OGKGtZ3Ia8
RT @msirota84: So proud of @ParanjpeIshan, my lab alumni for leading this analytical effort!
RT @LWestafer: My oh my is this article on anticoagulation in #covid19 going to unduly influence practice. before you read it just remember…
RT @MattMollpulmccm: Very nice comments. Important study, not definitive, not an rct. Thanks @aakonc @MiddeldorpS @connors_md https://t.co/…
RT @Cardio_delaGuia: Anticoagulación (AC) y Supervivencia Hospitalaria #COVID19 @JACCJournals ▪️ El 28% recibieron AC sistémica ▪️ Los que…
RT @aakonc: A more detailed look at this @JACCJournals #COVID19 anticoagulant study, linked here: https://t.co/h5ZhWPyv9f Key takeaways: 1…
My oh my is this article on anticoagulation in #covid19 going to unduly influence practice. before you read it just remember - you can't get a medication if you're not alive to receive it #immortaltimebias https://t.co/j38K78JRVl
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @danleisman: Ping @matthieulegrand
"Association of Treatment Dose #Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19" Pre-published data by @MountSinaiNYC team in @ACCinTouch #SARSCoV2 https://t.co/tH8Md9SI3W
RT @Angiologist: Does this paper answer the question of FULL DOSE anticoagulation in #COVID19? I don't think so @JACCJournals... e.g. limi…
RT @Angiologist: Does this paper answer the question of FULL DOSE anticoagulation in #COVID19? I don't think so @JACCJournals... e.g. limi…
RT @RodrigoZoniOK: A light of hope. In @JACCJournals was published an observational trial that place at @MountSinaiNYC where the anticoagul…
RT @EmilyBlyth5: Published in @JACCJournals #Anticoagulation in 2773 #Covid_19 patients admitted to Mt Sinai. Improved mortality in those t…
Short report (too short) of an observational study suggests that fully anticoagulated patients do better in terms of survival if they are admitted with COVID-19, especially if they need ventilation. What were indications for anticoagulation? Need RCT. http
@RonnySuarez_ No. Ese artículo no concluye eso. Se encontró asociación. No causalidad. El diseño del estudio no permite decir que los anticoagulantes hacen eso. Permite crear una hipótesis para realizar un diseño de estudio que permita dar esa respuesta.